| Name | Mapleton Care Center |
|---|---|
| Location | 115 Ingalls St, Lakewood, Colorado |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 90 |
| Occupancy Rate | 62.67% |
| Medicare ID (CCN) | 065097 |
| Legal Business Name | Mile High Care Services Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1750431912 |
| Organization Name | MILE HIGH CARE SERVICES LLC |
| Address | 115 Ingalls St, Lakewood, CO 80226 |
| Phone Number | 303-237-1325 |
News Archive
Oncotarget recently published "Simvastatin is a potential candidate drug in ovarian clear cell carcinomas" which reported that based on previous studies, the authors assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G, and one high-grade serous ovarian cancer cell line, Caov3. The authors used the Rho GTPase interfering drug CID-1067700 as a control.
Small rises of blood pressure may greatly increase a person's risk of stroke, according to new research. The study review, published in the journal Neurology, analyzed the results of 12 studies on blood pressure and stroke incidences among a total of 518,520 adults.
Royal Philips, a global leader in health technology, has announced the introduction of the next generation mask in its award-winning DreamWear full face mask system.
Damage to parts of the orbitofrontal cortex heightens monkeys' defensive response to non-threatening stimuli, according to new research published in JNeurosci. The study proposes a critical role for subregions of this brain area in different anxiety disorders.
› Verified 1 days ago
| NPI Number | 1891405650 |
| Organization Name | CASTLE ROCK HEALTHCARE, INC. |
| Address | 115 Ingalls St, Lakewood, CO 80226 |
| Phone Number | 303-237-1325 |
News Archive
Oncotarget recently published "Simvastatin is a potential candidate drug in ovarian clear cell carcinomas" which reported that based on previous studies, the authors assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G, and one high-grade serous ovarian cancer cell line, Caov3. The authors used the Rho GTPase interfering drug CID-1067700 as a control.
Small rises of blood pressure may greatly increase a person's risk of stroke, according to new research. The study review, published in the journal Neurology, analyzed the results of 12 studies on blood pressure and stroke incidences among a total of 518,520 adults.
Royal Philips, a global leader in health technology, has announced the introduction of the next generation mask in its award-winning DreamWear full face mask system.
Damage to parts of the orbitofrontal cortex heightens monkeys' defensive response to non-threatening stimuli, according to new research published in JNeurosci. The study proposes a critical role for subregions of this brain area in different anxiety disorders.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Oncotarget recently published "Simvastatin is a potential candidate drug in ovarian clear cell carcinomas" which reported that based on previous studies, the authors assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G, and one high-grade serous ovarian cancer cell line, Caov3. The authors used the Rho GTPase interfering drug CID-1067700 as a control.
Small rises of blood pressure may greatly increase a person's risk of stroke, according to new research. The study review, published in the journal Neurology, analyzed the results of 12 studies on blood pressure and stroke incidences among a total of 518,520 adults.
Royal Philips, a global leader in health technology, has announced the introduction of the next generation mask in its award-winning DreamWear full face mask system.
Damage to parts of the orbitofrontal cortex heightens monkeys' defensive response to non-threatening stimuli, according to new research published in JNeurosci. The study proposes a critical role for subregions of this brain area in different anxiety disorders.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.11 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.37 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 54.87 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.38 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.92 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.5 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.42 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.79 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 11.21 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 79.41 | 83.88 |